(Q40493325)

21 September 2017

title

Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys (English)

1 reference

21 September 2017

0 references

0 references

1 reference

R Galler

1

1 reference

21 September 2017

R S Marchevsky

2

1 reference

21 September 2017

E Caride

3

1 reference

21 September 2017

L F C Almeida

4

1 reference

21 September 2017

A M Y Yamamura

5

1 reference

21 September 2017

A V Jabor

6

1 reference

21 September 2017

M C A Motta

7

1 reference

21 September 2017

M C Bonaldo

8

1 reference

21 September 2017

E S F Coutinho

9

1 reference

21 September 2017

M S Freire

10

1 reference

21 September 2017

language of work or name

English

0 references

publication date

9 November 2005

1 reference

Brazilian Journal of Medical and Biological Research

21 September 2017

published in

1 reference

21 September 2017

volume

38

1 reference

21 September 2017

issue

12

1 reference

21 September 2017

page(s)

1835-1846

1 reference

Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Live attenuated tetravalent dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Traditional and novel approaches to flavivirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Construction of intertypic chimeric dengue viruses by substitution of structural protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Yellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Dengue: defining protective versus pathologic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Dengue encephalitis in French Guiana

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Neurovirulence detection of dengue virus using rhesus and cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

Dengue-4 vaccine: neurovirulence, viraemia and immune responses in rhesus and cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2005001200012

10.1590/S0100-879X2005001200012

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference